Crossmark

Tumor targeting peptide TMTP1 modified Antigen capture Nano-vaccine combined with chemotherapy and PD-L1 blockade effectively inhibits growth of ovarian cancer

Crossref DOI link: https://doi.org/10.1186/s12951-024-02744-6

Published Online: 2024-08-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Ying

Wei, Rui

Wang, Ling

Li, Jie

Wang, Wei

Jiang, Guiying

Tan, Songwei

Li, Fei

Wang, Xueqian

Ma, Xiangyi

Xi, Ling
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82102884)

National Natural Science Foundation of China (82002764)

National Natural Science Foundation of China (82272628)

National Natural Science Foundation of China (82172717)
License Information

Text and Data Mining valid from 2024-08-13

Version of Record valid from 2024-08-13
More Information

Article History

Received: 11 December 2023

Accepted: 2 August 2024

First Online: 13 August 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below